Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Colorcon
Federal Trade Commission
UBS
Argus Health
QuintilesIMS

Generated: March 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Selumetinib

« Back to Dashboard

US Patents for Selumetinib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Selumetinib ➤ Sign Up N3 alkylated benzimidazole derivatives as MEK inhibitors Array BioPharma, Inc. (Boulder, CO) ➤ Sign Up
Selumetinib ➤ Sign Up N3 alkylated benzimidazole derivatives as MEK inhibitors Array BioPharma Inc. (Boulder, CO) ➤ Sign Up
Selumetinib ➤ Sign Up N3 alkylated benzimidazole derivatives as MEK inhibitors Array BioPharma Inc. (Boulder, CO) ➤ Sign Up
Selumetinib ➤ Sign Up N3 alkylated benzimidazole derivatives as MEK inhibitors Array BioPharma Inc. (Boulder, CO) ➤ Sign Up
Selumetinib ➤ Sign Up N3 alkylated benzimidazole derivatives as MEK inhibitors Array BioPharma Inc. (Boulder, CO) ➤ Sign Up
Selumetinib ➤ Sign Up N3 alkylated benzimidazole derivatives as MEK inhibitors Array BioPharma Inc. (Boulder, CO) ➤ Sign Up
Selumetinib ➤ Sign Up N3 alkylated benzimidazole derivatives as MEK inhibitors Array BioPharma Inc. (Boulder, CO) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Selumetinib

Drugname Country Document Number Estimated Expiration Related US Patent
Selumetinib Argentina 038971 2022-03-13 ➤ Sign Up
Selumetinib Argentina 045738 2022-03-13 ➤ Sign Up
Selumetinib Argentina 090143 2022-03-13 ➤ Sign Up
Selumetinib Argentina 090144 2022-03-13 ➤ Sign Up
Selumetinib Austria 449605 2022-03-13 ➤ Sign Up
Selumetinib Australia 2003218157 2022-03-13 ➤ Sign Up
Selumetinib Australia 2004270166 2022-03-13 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Citi
McKesson
US Department of Justice
Healthtrust
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.